Lystra Wilson Celestine, MD
Obstetrics & Gynecology · Grass Valley, CANPI 1003034018
Payments from drug & device makers
Across 61 payments — averaging $146.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Pfizer$221
- Myriad Women's Health, Inc.$91
- AbbVie$75
- Sumitomo Pharma America, Inc.$36
- Minerva Surgical, Inc$32
- plus $108 from 6 others
What the payments were for
- Travel & lodging$1,48317%
- Food & beverage$1,92722%
- Education$5,51762%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 34 | $8,373 |
| Pfizer | 12 | $221 |
| Myriad Women's Health, Inc. | 1 | $91 |
| AbbVie | 4 | $75 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Minerva Surgical, Inc | 1 | $32 |
| Organon | 2 | $26 |
| Evofem Biosciences, Inc. | 1 | $24 |
| Scynexis, Inc. | 1 | $16 |
| Myovant Sciences Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$5,500
- Da Vinci Surgical System$2,174
How this compares
$8,935 in reported general payments places this provider in the 90th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 160 | $7,484 |
| ProgesteroneProgesterone, Micronized | 154 | $6,270 |
| Estradiol (Twice Weekly)Estradiol | 38 | $3,925 |
| YuvafemEstradiol | 24 | $3,890 |
| Estradiol (Once Weekly)Estradiol | 46 | $2,511 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $870 |
| Clobetasol Propionate | 18 | $344 |
| Triamcinolone Acetonide | 14 | $62 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Grass Valley
- Peyman BanooniBeverly Hills$9.2M
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
- Oleg BessLos Angeles$1.7M
- Rovena ReaganSan Diego$1.7M
- Dana Shippdel Mar$1.7M
- Vanessa JacobySan Francisco$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.